Vanguard Group Inc Ligand Pharmaceuticals Inc Transaction History

Vanguard Group Inc

  • $5.37 Trillion
  • Q1 2025

A detailed history of Vanguard Group Inc transactions in Ligand Pharmaceuticals Inc stock. As of the latest transaction made, Vanguard Group Inc holds 2,055,732 shares of LGND stock, worth $283 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
2,055,732
Previous 2,085,627 1.43%
Holding current value
$283 Million
Previous $223 Million 3.28%
% of portfolio
0.0%
Previous 0.0%

Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

May 09, 2025
SELL
$105.14 - $122.23 $3.14 Million - $3.65 Million
-29,895 Reduced 1.43%
2,055,732 $216 Million
Q4 2024

Feb 11, 2025
BUY
$99.95 - $129.9 $11.5 Million - $14.9 Million
115,005 Added 5.84%
2,085,627 $223 Million
Q3 2024

Nov 13, 2024
BUY
$82.7 - $110.11 $3.62 Million - $4.82 Million
43,748 Added 2.27%
1,970,622 $197 Million
Q2 2024

Aug 13, 2024
BUY
$68.53 - $87.91 $2.93 Million - $3.76 Million
42,762 Added 2.27%
1,926,874 $162 Million
Q1 2024

May 10, 2024
BUY
$68.64 - $89.2 $521,526 - $677,741
7,598 Added 0.4%
1,884,112 $138 Million
Q4 2023

Feb 14, 2024
BUY
$49.57 - $72.63 $1.22 Million - $1.79 Million
24,653 Added 1.33%
1,876,514 $134 Million
Q3 2023

Nov 14, 2023
SELL
$58.86 - $72.67 $87,819 - $108,423
-1,492 Reduced 0.08%
1,851,861 $111 Million
Q2 2023

Aug 14, 2023
SELL
$69.53 - $79.33 $365,797 - $417,355
-5,261 Reduced 0.28%
1,853,353 $134 Million
Q1 2023

May 15, 2023
BUY
$65.67 - $77.08 $1.02 Million - $1.19 Million
15,499 Added 0.84%
1,858,614 $137 Million
Q4 2022

Feb 10, 2023
BUY
$61.72 - $96.74 $3.07 Million - $4.81 Million
49,701 Added 2.77%
1,843,115 $123 Million
Q3 2022

Nov 14, 2022
BUY
$0.01 - $107.56 $194 - $2.09 Million
19,440 Added 1.1%
1,793,414 $154 Million
Q2 2022

Aug 12, 2022
BUY
$74.52 - $117.06 $3.45 Million - $5.42 Million
46,336 Added 2.68%
1,773,974 $158 Million
Q1 2022

May 13, 2022
BUY
$94.99 - $151.56 $1.04 Million - $1.65 Million
10,903 Added 0.64%
1,727,638 $194 Million
Q4 2021

Feb 14, 2022
SELL
$127.69 - $165.85 $709,445 - $921,462
-5,556 Reduced 0.32%
1,716,735 $265 Million
Q3 2021

Nov 12, 2021
BUY
$102.33 - $144.73 $20.3 Million - $28.7 Million
198,136 Added 13.0%
1,722,291 $240 Million
Q2 2021

Aug 13, 2021
BUY
$113.03 - $155.64 $172 Million - $237 Million
1,524,155 New
1,524,155 $200 Million

Others Institutions Holding LGND

# of Institutions
282
Shares Held
19M
Call Options Held
9.5K
Put Options Held
8.1K
View Full List

About LIGAND PHARMACEUTICALS INC

LGND Quotes by TradingView
  • Ticker LGND
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 16,882,800
  • Market Cap $2.32B
  • Description
  • Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, focuses on developing or acquiring technologies that help pharmaceutical companies to discover and develop medicines worldwide. Its commercial programs include Kyprolis and Evomela, which are used to treat multiple myeloma; Veklury for the treatment of moderate or severe COVID-19;...
More about LGND
Track This Portfolio

Track Vanguard Group Inc Portfolio

Follow Vanguard Group Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Vanguard Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Vanguard Group Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email